Discover 1,381 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,381
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Garfield OH, Westlake OH, Avon Lake OH,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms
for
PARKINSON DISEASE (Disorder)
Location: Cleveland OH
Sponsor: U: The Mind Company
Sex: All
Age: 18 - 70+
Code: NCT07182058
Phase1, Phase2, Recruiting
Active & Responsive
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
for
Generalized Anxiety Disorder
Location: Cleveland OH, Chicago IL, Moosic PA, Philadelphia PA,
Sponsor: Definium Therapeutics US, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06741228
Phase3, Recruiting
Active & Responsive
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
for
Obstructive Sleep Apnea of Adult, Preeclampsia,
Location: Cleveland OH, Pittsburgh PA, Columbus OH, Chicago IL,
Sponsor: The George Washington University Biostatistics Center
Sex: Female
Age: 18+
Code: NCT03487185
Recruiting
Active & Responsive
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
for
Juvenile Psoriatic Arthritis
Location: Cleveland OH, Toronto, Indianapolis IN,
Sponsor: AbbVie
Sex: All
Age: 5 - 17
Code: NCT06100744
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Lupus Landmark Study: A Prospective Registry and Biorepository
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
for
Migraine
Location: Cleveland OH, Ann Arbor MI, Columbus OH, Morgantown WV,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06417775
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis